|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stacey Treichler, PhD, believes the development process for new biologics is complex and requires a substantial amount of time and resources, and reviews some of the areas where careful choice of CDMO is key, including cell line development and cGMP manufacturing capabilities, and how an integrated approach can be beneficial.
|
|
|
Alfred Harvey, MBA, MS, discusses how differences in primary container options for injectable drugs can add value by offering hospitals and care centers configurations that address universal pain points.
|
|
|
Kamna Jhamb, PhD, says the highly regulated nature of the pharmaceutical sector, and the low-risk-taking nature of this market, are the two main factors that have restrained the implementation of novel methods of manufacturing by pharmaceutical industries. However, the burgeoning demand for complex and innovative therapies and rising competition have led pharmaceutical manufacturers to reconsider their methods of manufacturing.
|
|
|
Daniel de Boer, Chief Executive Officer of ProQR, discusses the use of RNA technology to directly target the underlying cause of genetic diseases.
|
|
|
For each participating company, this section presents a detailed summary highlighting their core technologies, capabilities, technologies, and services.
|
|
|
|
|
|
|
|
|

ARL Bio Pharma is a contract laboratory that provides analytical and microbiological testing to pharmaceutical companies and research scientists. Our laboratory is headquartered in Oklahoma City, Oklahoma, and serves over 3,000 clients nationwide. Since 1998, ARL has supported the industry-wide commitment to deliver high-quality therapeutic drug products by providing guidance and test services for all phases of the product lifecycle following USP, FDA, and ICH guidelines. Whether you are an innovator or pharmaceutical manufacturer, we provide the testing needed to get your pharmaceutical products to market. ARL’s dedicated team oversees the entire process from understanding your product goals to providing results and helping interpret the data. ARL is FDA registered and audited, ISO 17025 accredited and DEA licensed for Schedules I through V. Our laboratory maintains programs that support continuous improvement yielding over 20 years of quality service through experience and excellence. Click here for more.
|
|
|
|
|
|
 |
|
Recipharm, the contract development and manufacturing organisation (CDMO), recently announced ongoing large-scale commercial manufacturing of RedHill Biopharma’s drug, Talicia (omeprazole magnesium,…..
|
|
 |
|
PPD, Inc. has expanded its early development research services by adding significant neuroscience and ethno-bridging expertise, broadening its capabilities to provide increased access to…..
|
|
 |
|
Beta Bionics, Inc., a medical technology company developing and aiming to commercialize the world’s first fully automated bionic pancreas, recently announced its bionic pancreas glucose control algorithms that use lifelong autonomous learning were deployed in….
|
|
|
|
|
Upcoming eNewsletter Features:
December 11 – Controlled Release
December 18 – Parenteral Contract Manufacturing
|
|
|
|
|
|
|
|